Landos Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LABP and buy or sell other stocks, ETFs, and their options commission-free!About LABP
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway.
CEOGregory Oakes, MBA
CEOGregory Oakes, MBA
Employees—
Employees—
HeadquartersRoanoke, Virginia
HeadquartersRoanoke, Virginia
Founded2017
Founded2017
Employees—
Employees—
LABP Key Statistics
Market cap71.47M
Market cap71.47M
Price-Earnings ratio-5.74
Price-Earnings ratio-5.74
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$22.94
52 Week high$22.94
52 Week low$21.90
52 Week low$21.90
Stock Snapshot
Landos Biopharma(LABP) stock is priced at $3.39, giving the company a market capitalization of 71.47M. It carries a P/E multiple of -5.74.
Landos Biopharma(LABP) stock opened on 2025-12-07 at —. The price climbed to — and dipped to —.
Landos Biopharma(LABP) shares are trading with a volume of 0.
In the last year, Landos Biopharma(LABP) shares hit a 52-week high of $22.94 and a 52-week low of $21.90.
In the last year, Landos Biopharma(LABP) shares hit a 52-week high of $22.94 and a 52-week low of $21.90.
People also own
Based on the portfolios of people who own LABP. This list is generated using Robinhood data, and it’s not a recommendation.